News

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...
As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...
A rare case of Epstein-Barr virus-induced Bell palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
Dec. 16, 2024 — To fight the virus that causes influenza, one of the avenues being explored by scientists is the development of drugs capable of destabilizing its genome, made up of RNA molecules.
Thimerosal is an organomercury preservative used in vaccines and other biological products, distinguished by its rapid ...
Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial.
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...